Celgene Corp Celg Presents At Morgan Stanley Global Healthcare Conference Call Transcript | Latest News RSS feed

Celgene Corp Celg Presents At Morgan Stanley Global Healthcare Conference Call Transcript - Latest News


Celgene Corp. (CELG) Presents at Morgan Stanley Global Healthcare Conference Call Transcript

Celgene Corp. (NASDAQ:CELG) Morgan Stanley Global Healthcare Conference Call September 14, 2018 11:40 AM ET Executives Nadim Ahmed - President, Hematology & Oncology David Elkins - CFO Analysts Matthe... read more

CVS Caremark's Management Presents at 2013 Morgan Stanley Healthcare Conference (Transcript)

CVS Caremark Corporation (CVS) 2013 Morgan Stanley Healthcare Conference September 10 ... On our second quarter call those that may have listened in back in early August, we reported a gross new wins ... read more

Top Analyst Upgrades and Downgrades (AMP, AZO, BHI, CELG, DDS, EMC, FRT, GNW, HAL, MYL, NOC, NYX, PNK, RTN, SNH, SBY, LUV, JBLU, MET, HIG)

AutoZone Inc. (NYSE: AZO) cut to Underweight at Morgan Stanley. Baker Hughes Inc. (NYSE: BHI) cut to Neutral at Stern Agee. Celgene Corp. (NASDAQ: CELG) raised to Overweight at Piper Jaffray, raised t... read more

Looking for another news?


Technical Reports on Biotech Equities -- Celgene, Dynavax Technologies, Keryx Biopharma, and Moleculin Biotech

For assessment this morning are these four stocks: Celgene Corp. (NASDAQ: CELG), Dynavax Technologies Corp. (NASDAQ: DVAX), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), and Moleculin Biotech Inc. (NA... read more


Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW

Today, Analysts Review released its analysts' notes regarding Merck & Co. Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), UnitedHealth Group Inc. (NYSE: UNH), Celgene Corporation (NASDAQ: CELG) and G... read more

UPDATE: Nomura Reiterates on salesforce.com Following Solid 3Q, Dreamforce Analyst Meeting

We are attending this and the company's analyst meeting. Revenue growth of 36% was a bit above the Street expectation of 33%. Billings growth of 37% (we estimate 26% on an organic, cc basis) was also ... read more

Celgene (CELG) Management Presents at Morgan Stanley Global Healthcare Unplugged Conference - Brokers Conference Transcript

Celgene Corp (NASDAQ:CELG) Morgan Stanley Global Healthcare Unplugged Conference Call September 12, 2016 2:50 PM ET Executives Scott Smith - President, Global Inflammation and Immunology Analysts Matt... read more

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Celgene Corp. (NASDAQ: CELG) was started as Outperform and assigned a $141 ... was downgraded to Underweight from Overweight with a $59 price target (versus a $66.32 close) at Morgan Stanley. The 52-w... read more

Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus

Shares of bigwig Celgene ... Corporation CELG surged on a takeover offer from Bristol-Myers Squibb Company, while Loxo Oncology LOXO surged on an acquisition offer from Eli Lilly. Meanwhile, the focus ... read more

Healthcare: Is Celgene Going to Buy Juno Therapeutics?

Rumors are swirling that Celgene Corp. (NASDAQ: CELG) may pay billions of dollars to buy Juno Therapeutics (NASDAQ ... I was at the JP Morgan Healthcare Conference in San Francisco. This is the bigges... read more

Sanofi beats Novo to buy Ablynx for 3.9 billion euros in biotech M&A boom

PARIS/LONDON (Reuters) - French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion ... dollar deals in biotech, with U.S.-based Celgene payi... read more

3 Top Stocks After #ASH18

Positive trial data unveiled at the American Society of Hematology conference makes these top stocks to watch in 2019. Positive trial data unveiled at the American Society of Hematology conference mak... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us